JASON HAM: Open Payments
NPI 1245560796 · FORT PAYNE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 44 payments from 18 companies in 2025. Trend: 2023 $615 · 2024 $651 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $153 |
| Lilly USA, LLC | 5 | $100 |
| Ardelyx, Inc. | 4 | $84 |
| Vanda Pharmaceuticals Inc. | 3 | $72 |
| Sumitomo Pharma America, Inc. | 3 | $69 |
| Axsome Therapeutics, Inc. | 4 | $60 |
| PFIZER INC. | 3 | $49 |
| Corcept Therapeutics | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
Products named: IBSRELA, MOUNJARO, FANAPT, GEMTESA, Auvelity, Rybelsus, Ozempic, JARDIANCE.
Industry payments across AL — which companies pay providers there.
